1,452
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Clinical Decision Support System: A Pragmatic Tool to Improve Acute Exacerbation of COPD Discharge Recommendations

, , & , MD
Pages 18-24 | Received 14 Jan 2019, Accepted 06 Mar 2019, Published online: 04 Apr 2019

Figures & data

Figure 1. The above EHR-based CDS tool was placed in the patient care workflow after confirmation of the AECOPD diagnosis and before completion of discharge medications and recommendations. The tool is launched automatically in the navigator menu. Once the physician selects one of the long-acting bronchodilators shown above then a menu with all of the relevant inhalers for that specific category is shown (e.g. “INH. Tiotropium bromide 2.5 mcg/puff 2-puffs OD”). The recommendations selected by the physician will automatically convert into prescriptions and written recommendations that will appear in the discharge letter.

Figure 1. The above EHR-based CDS tool was placed in the patient care workflow after confirmation of the AECOPD diagnosis and before completion of discharge medications and recommendations. The tool is launched automatically in the navigator menu. Once the physician selects one of the long-acting bronchodilators shown above then a menu with all of the relevant inhalers for that specific category is shown (e.g. “INH. Tiotropium bromide 2.5 mcg/puff 2-puffs OD”). The recommendations selected by the physician will automatically convert into prescriptions and written recommendations that will appear in the discharge letter.

Table 1. Baseline characteristics of hospital admissions for AECOPD, before and after the integration of the CDS tool into the EHR system.

Figure 2. Changes in adherence to guideline-based discharge recommendations before and after implementation of the CDS tool. All the differences are statistically significant p < 0.001.

Figure 2. Changes in adherence to guideline-based discharge recommendations before and after implementation of the CDS tool. All the differences are statistically significant p < 0.001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.